Status:
ACTIVE_NOT_RECRUITING
Personalized Exercise Oncology
Lead Sponsor:
University Hospital Heidelberg
Collaborating Sponsors:
Penn State University
Conditions:
Cancer
Health Behavior
Eligibility:
All Genders
18+ years
Brief Summary
The Goal of the study is to identify trait-homogenous groups of cancer patients in regards to their physical activity associated health literacy. Based on these Groups, individualized exercise protoco...
Eligibility Criteria
Inclusion
- Histologically confirmed cancer diagnosis
- Females and males ≥18 years of age
- Undergoing either chemo-, immune-, radio- or anti-hormonal treatment
- Last surgery more than 6 weeks in the past
- Ability to understand English or German
- Be able to provide and understand informed consent
- Have an Eastern Cooperative Oncology Group (ECOG) Performance Score of ≤ 2
Exclusion
- Heart insufficiency \> NYHA III (New York Heart Association) or uncertain arrhythmia
- Uncontrolled hypertension
- Severe renal dysfunction (GFR \< 30%, Creatinine\> 3mg/dl)
- Reduced standing or walking
- Current pregnancy
- Any other evidence in the medical record of an absolute contraindication for exercise
Key Trial Info
Start Date :
November 26 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04328038
Start Date
November 26 2018
End Date
February 1 2026
Last Update
February 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heidelberg University Hospital
Heidelberg, Germany, 69120